Looking back: does this HAE drug work in everyday life?
NCT ID NCT07263685
Summary
This study aims to understand how well the preventive drug Takhzyro works for people with hereditary angioedema (HAE) in real-world settings in Saudi Arabia. Researchers will review the medical records of about 50 patients who have taken the drug for at least six months to see if it reduced their swelling attacks and improved their quality of life. No new treatment is given; the study only looks at past patient data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Faisal Specialist Hospital and Research Centre
Riyadh, 12713, Saudi Arabia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.